227 related articles for article (PubMed ID: 8392306)
1. Novel gyrA point mutation in a strain of Escherichia coli resistant to fluoroquinolones but not to nalidixic acid.
Cambau E; Bordon F; Collatz E; Gutmann L
Antimicrob Agents Chemother; 1993 Jun; 37(6):1247-52. PubMed ID: 8392306
[TBL] [Abstract][Full Text] [Related]
2. Detection of gyrA and gyrB mutations in quinolone-resistant clinical isolates of Escherichia coli by single-strand conformational polymorphism analysis and determination of levels of resistance conferred by two different single gyrA mutations.
Ouabdesselam S; Hooper DC; Tankovic J; Soussy CJ
Antimicrob Agents Chemother; 1995 Aug; 39(8):1667-70. PubMed ID: 7486897
[TBL] [Abstract][Full Text] [Related]
3. A novel, double mutation in DNA gyrase A of Escherichia coli conferring resistance to quinolone antibiotics.
Truong QC; Nguyen Van JC; Shlaes D; Gutmann L; Moreau NJ
Antimicrob Agents Chemother; 1997 Jan; 41(1):85-90. PubMed ID: 8980760
[TBL] [Abstract][Full Text] [Related]
4. Detection of mutations in the gyrA and parC genes in quinolone-resistant clinical isolates of Enterobacter cloacae.
Deguchi T; Yasuda M; Nakano M; Ozeki S; Kanematsu E; Nishino Y; Ishihara S; Kawada Y
J Antimicrob Chemother; 1997 Oct; 40(4):543-9. PubMed ID: 9372424
[TBL] [Abstract][Full Text] [Related]
5. Development of a rapid assay for detecting gyrA mutations in Escherichia coli and determination of incidence of gyrA mutations in clinical strains isolated from patients with complicated urinary tract infections.
Ozeki S; Deguchi T; Yasuda M; Nakano M; Kawamura T; Nishino Y; Kawada Y
J Clin Microbiol; 1997 Sep; 35(9):2315-9. PubMed ID: 9276409
[TBL] [Abstract][Full Text] [Related]
6. Mutations in the gyrA gene of a highly fluoroquinolone-resistant clinical isolate of Escherichia coli.
Heisig P; Schedletzky H; Falkenstein-Paul H
Antimicrob Agents Chemother; 1993 Apr; 37(4):696-701. PubMed ID: 8388197
[TBL] [Abstract][Full Text] [Related]
7. Single or double mutational alterations of gyrA associated with fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli.
Bachoual R; Ouabdesselam S; Mory F; Lascols C; Soussy CJ; Tankovic J
Microb Drug Resist; 2001; 7(3):257-61. PubMed ID: 11759087
[TBL] [Abstract][Full Text] [Related]
8. Mutations in gyrA and parC genes in nalidixic acid-resistant Escherichia coli strains from food products, humans and animals.
Sáenz Y; Zarazaga M; Briñas L; Ruiz-Larrea F; Torres C
J Antimicrob Chemother; 2003 Apr; 51(4):1001-5. PubMed ID: 12654733
[TBL] [Abstract][Full Text] [Related]
9. Quinolone resistance mutations in the gyrA gene of clinical isolates of Salmonella.
Ouabdesselam S; Tankovic J; Soussy CJ
Microb Drug Resist; 1996; 2(3):299-302. PubMed ID: 9158789
[TBL] [Abstract][Full Text] [Related]
10. [Mutations of gyrA in ciprofloxacin resistant Escherichia coli strains].
Eraç B; Gill A; Amyes SG; Gülay Z
Mikrobiyol Bul; 2003; 37(2-3):125-30. PubMed ID: 14593893
[TBL] [Abstract][Full Text] [Related]
11. Genetic evidence for a role of parC mutations in development of high-level fluoroquinolone resistance in Escherichia coli.
Heisig P
Antimicrob Agents Chemother; 1996 Apr; 40(4):879-85. PubMed ID: 8849244
[TBL] [Abstract][Full Text] [Related]
12. Association between double mutation in gyrA gene of ciprofloxacin-resistant clinical isolates of Escherichia coli and MICs.
Vila J; Ruiz J; Marco F; Barcelo A; Goñi P; Giralt E; Jimenez de Anta T
Antimicrob Agents Chemother; 1994 Oct; 38(10):2477-9. PubMed ID: 7840592
[TBL] [Abstract][Full Text] [Related]
13. gyrA mutations in high-level fluoroquinolone-resistant clinical isolates of Escherichia coli.
Conrad S; Oethinger M; Kaifel K; Klotz G; Marre R; Kern WV
J Antimicrob Chemother; 1996 Sep; 38(3):443-55. PubMed ID: 8889719
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of quinolone resistance in a clinical isolate of Escherichia coli highly resistant to fluoroquinolones but susceptible to nalidixic acid.
Moniot-Ville N; Guibert J; Moreau N; Acar JF; Collatz E; Gutmann L
Antimicrob Agents Chemother; 1991 Mar; 35(3):519-23. PubMed ID: 2039202
[TBL] [Abstract][Full Text] [Related]
15. Ciprofloxacin and the fluoroquinolones. New concepts on the mechanism of action and resistance.
Fisher LM; Lawrence JM; Josty IC; Hopewell R; Margerrison EE; Cullen ME
Am J Med; 1989 Nov; 87(5A):2S-8S. PubMed ID: 2574005
[TBL] [Abstract][Full Text] [Related]
16. Complete nucleotide sequence of the gyrA gene of Helicobacter pullorum and identification of a point mutation leading to ciprofloxacin resistance in poultry isolates.
Pasquali F; Rossi M; Manfreda G; Zanoni R
Int J Antimicrob Agents; 2007 Sep; 30(3):222-8. PubMed ID: 17644320
[TBL] [Abstract][Full Text] [Related]
17. Characterization of fluoroquinolone-resistant mutants of escherichia coli selected in vitro.
Heisig P; Tschorny R
Antimicrob Agents Chemother; 1994 Jun; 38(6):1284-91. PubMed ID: 8092826
[TBL] [Abstract][Full Text] [Related]
18. Construction of a gyrA plasmid for genetic characterization of fluoroquinolone-resistant Staphylococcus aureus.
Tankovic J; Duval J; Courvalin P
FEMS Immunol Med Microbiol; 1994 Jun; 9(1):35-9. PubMed ID: 7920462
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the mechanisms of quinolone resistance in clinical isolates of Citrobacter freundii.
Navia MM; Ruiz J; Ribera A; de Anta MT; Vila J
J Antimicrob Chemother; 1999 Dec; 44(6):743-8. PubMed ID: 10590274
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the mechanism of quinolone resistance in nalidixic acid-resistant clinical isolates of Salmonella serotype Typhimurium.
Ruiz J; Castro D; Goñi P; Santamaria JA; Borrego JJ; Vila J
J Med Microbiol; 1997 Jul; 46(7):623-8. PubMed ID: 9236748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
